This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Technische Unversität Berlin. Active years: 2020.
Company Filing History:
Years Active: 2020
Title: Ahmet Hazini: Innovator in Cancer Treatment
Introduction
Ahmet Hazini is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of cancer treatment through his innovative research and development. His work focuses on utilizing a modified Coxsackievirus B3 variant to target cancer cells effectively.
Latest Patents
Ahmet Hazini holds a patent for a method for treating cancer with a Coxsackievirus B3 (CVB3) variant. The patent describes a method that involves administering a therapeutically effective amount of the virus to a subject in need. This method specifically targets cancer cells that express a heparan sulfate (HS) receptor on their surface. The virus binds to the HS receptor, enters the cancer cells, and accumulates within them, leading to viral lysis of at least some cancer cells. He has 1 patent related to this groundbreaking treatment.
Career Highlights
Ahmet Hazini is affiliated with Technische Universität Berlin, where he conducts his research and collaborates with other experts in the field. His work has garnered attention for its potential to revolutionize cancer treatment methodologies.
Collaborations
Ahmet Hazini has worked alongside notable colleagues, including Henry Fechner and Vanessa Brueckner. Their collaborative efforts contribute to the advancement of innovative cancer therapies.
Conclusion
Ahmet Hazini's contributions to cancer treatment through his patented method highlight the importance of innovation in medical research. His work exemplifies the potential of using viral therapies to combat cancer effectively.